|
Allen, R.C., Armitage, R.J., Conley, M.E., Rosenblatt, H., Jenkins, N.A., Copeland, N.G., Bedell, M.A., Edelhoff, S., Disteche, C.M., Simoneaux, D.K., Fanslow, W.C., Belmont, J., and Spiggs, M.K. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science, 259, 990-3.
Arch, R.H., Gedrich, R.W. and Thompson, C.B. (1998) Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. Genes Dev, 12, 2821-30.
Ashkenazi, A. and Dixit, V.M. (1998) Death receptors: signaling and modulation. Science, 281, 1305-8.
Ashkenazi, A. and Dixit, V.M. (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol, 11, 255-60.
Baker, S.J. and Reddy, E.P. (1998) Modulation of life and death by the TNF receptor superfamily. Oncogene, 17, 3261-70.
Banner, D.W., D''Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.J., Broger, C., Loetscher, H. and Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell, 73, 431-45.
Beutler, B. and van Huffel, C. (1994) Unraveling function in the TNF ligand and receptor families [comment]. Science, 264, 667-8.
Blair, P.J., Riley, J.L., Harlan, D.M., Abe, R., Tadaki, D.K., Hoffmann, S.C., White, L., Francomano, T., Perfetto, S.J., Kirk, A.D. and June, C.H. (2000) CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J Exp Med, 191, 651-60.
Bodmer, J.L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J. and Tschopp, J. (2000) TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol, 2, 241-3.
Boldin, M.P., Goncharov, T.M., Goltsev, Y.V. and Wallach, D. (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell, 85, 803-15.
Browning, J.L., Dougas, I., Ngam, e.A., Bourdon, P.R., Ehrenfels, B.N., Miatkowski, K., Zafari, M., Yampaglia, A.M., Lawton, P., Meier, W. and et, a.l. (1995) Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J Immunol, 154, 33-46.
Browning, J.L., Miatkowski, K., Sizing, I., Griffiths, D., Zafari, M., Benjamin, C.D., Meier, W. and Mackay, F. (1996a) Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J Exp Med, 183, 867-78.
Browning, J.L., Miatkowski, K., Sizing, I., Griffiths, D., Zafari, M., Benjamin, C.D., Meier, W. and Mackay, F. (1996b) Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J Exp Med, 183, 867-78.
Browning, J.L., Ngam, e.A., Lawton, P., DeMarinis, J., Tizard, R., Chow, E.P., Hession, C., O''Brine, G.B., Foley, S.F. and Ware, C.F. (1993) Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell, 72, 847-56.
Chang, H.Y., Nishitoh, H., Yang, X., Ichijo, H. and Baltimore, D. (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science, 281, 1860-3.
Chaplin, D.D. and Fu, Y. (1998) Cytokine regulation of secondary lymphoid organ development. Curr Opin Immunol, 10, 289-97.
Chaudhary, P.M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J. and Hood, L. (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity, 7, 821-30.
Chen, C.M., You, L.R., Hwang, L.H. and Lee, Y.H. (1997) Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol, 71, 9417-26.
Chinnaiyan, A.M., O''Rourke, K., Tewari, M. and Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-12.
Chinnaiyan, A.M., O''Rourke, K., Yu, G.L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J. and Dixit, V.M. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science, 274, 990-2.
Crowe, P.D., VanArsdale, T.L., Walter, B.N., Ware, C.F., Hession, C., Ehrenfels, B., Browning, J.L., Din, W.S., Goodwin, R.G. and Smith, C.A. (1994) A lymphotoxin-beta-specific receptor. Science, 264, 707-10.
Dadgostar, H. and Cheng, G. (2000) Membrane localization of TRAF 3 enables JNK activation. J Biol Chem, 275, 2539-44.
Darnay, B.G., Singh, S. and Aggarwal, B.B. (1997) The p80 TNF receptor-associated kinase (p80TRAK) associates with residues 354-397 of the p80 cytoplasmic domain: similarity to casein kinase. FEBS Lett, 406, 101-5.
De Togni, P., Goellner, J., Ruddle, N.H., Streeter, P.R., Fick, A., Mariathasan, S., Smith, S.C., Carlson, R., Shornick, L.P., Strauss-Schoenberger, J. and et al. (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science, 264, 703-7.
Degli-Esposti, M.A., Davis-Smith, T., Din, W.S., Smolak, P.J., Goodwin, R.G. and Smith, C.A. (1997) Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. J Immunol, 158, 1756-62.
Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M. and Liu, Z. (2000) The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity, 12, 419-29.
Eby, M.T., Jasmin, A., Kumar, A., Sharma, K. and Chaudhary, P.M. (2000) TAJ, a Novel Member of the Tumor Necrosis Factor Receptor Family, Activates the c-Jun N-terminal Kinase Pathway and Mediates Caspase-independent Cell Death. J Biol Chem, 275, 15336-15342.
Eck, M.J. and Sprang, S.R. (1989) The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J Biol Chem, 264, 17595-605.
Ettinger, R., Browning, J.L., Michie, S.A., van Ewijk, W. and McDevitt, H.O. (1996) Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. Proc Natl Acad Sci U S A, 93, 13102-7.
Force, W.R., Cheung, T.C. and Ware, C.F. (1997) Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor. J Biol Chem, 272, 30835-40.
Force, W.R., Glass, A.A., Benedict, C.A., Cheung, T.C., Lama, J. and Ware, C.F. (2000) Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways. J Biol Chem, 275, 11121-9.
Force, W.R., Walter, B.N., Hession, C., Tizard, R., Kozak, C.A., Browning, J.L. and Ware, C.F. (1995) Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. Journal of Immunology, 155, 5280-8.
Fu, Y.X. and Chaplin, D.D. (1999) Development and maturation of secondary lymphoid tissues. Annu Rev Immunol, 17, 399-433.
Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M.H. and Pfeffer, K. (1998) The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity, 9, 59-70.
Gearing, A.J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.H., Drummond, A.H., Galloway, W.A., Gilbert, R., Gordon, J.L. and et al. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature, 370, 555-7.
Goeddel, D.V. (1999) Signal transduction by tumor necrosis factor: the Parker B. Francis Lectureship. Chest, 116, 69S-73S.
Hane, M., Lowin, B., Peitsch, M., Becker, K. and Tschopp, J. (1995) Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett, 373, 265-8.
Hoeflich, K.P., Yeh, W.C., Yao, Z., Mak, T.W. and Woodgett, J.R. (1999) Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene, 18, 5814-20.
Hollenbaugh, D., Grosmaire, L.S., Kullas, C.D., Chalupny, N.J., Braesch-Andersen, S., Noelle, R.J., Stamenkovic, I., Ledbetter, J.A. and Aruffo, A. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO Journal, 11, 4313-21.
Hsu, H., Huang, J., Shu, H.B., Baichwal, V. and Goeddel, D.V. (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4, 387-96.
Hsu, H., Xiong, J. and Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell, 81, 495-504.
Hu, H.M., O''Rourke, K., Boguski, M.S. and Dixit, V.M. (1994) A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem, 269, 30069-72.
Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K. and Gotoh, Y. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science, 275, 90-4.
Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S. and Yamamoto, T. (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res, 254, 14-24.
Itoh, N. and Nagata, S. (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem., 268, 10932-10937.
Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z. and Leder, P. (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity, 8, 297-303.
Kischkel, F.C., Lawrence, D.A., Chuntharapai, A., Schow, P., Kim, K.J. and Ashkenazi, A. (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity, 12, 611-20.
Kitson, J., Raven, T., Jiang, Y.P., Goeddel, D.V., Giles, K.M., Pun, K.T., Grinham, C.J., Brown, R. and Farrow, S.N. (1996) A death-domain-containing receptor that mediates apoptosis. Nature, 384, 372-5
.
Kwon, B., Youn, B.S. and Kwon, B.S. (1999) Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. Current Opinion in Immunology, 11, 340-5.
Lens, S.M., Drillenburg, P., den Drijver, B.F., van Schijndel, G., Pals, S.T., van Lier, R.A. and van Oers, M.H. (1999) Aberrant expression and reverse signalling of CD70 on malignant B cells. British Journal of Haematology, 106, 491-503.
Liu, Z.G., Hsu, H., Goeddel, D.V. and Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell, 87, 565-76.
Lomaga, M.A., Yeh, W.C., Sarosi, I., Duncan, G.S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., van der Heiden, A., Itie, A., Wakeham, A., Khoo, W., Sasaki, T., Cao, Z., Penninger, J.M., Paige, C.J., Lacey, D.L., Dunstan, C.R., Boyle, W.J., Goeddel, D.V. and Mak, T.W. (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev, 13, 1015-24.
Mackay, F., Majeau, G.R., Hochman, P.S. and Browning, J.L. (1996) Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappaB transcription factor in some cell types. J Biol Chem, 271, 24934-8.
Malinin, N.L., Boldin, M.P., Kovalenko, A.V. and Wallach, D. (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature, 385, 540-4.
Mauri, D.N., Ebner, R., Montgomery, R.I., Kochel, K.D., Cheung, T.C., Yu, G.L., Ruben, S., Murphy, M., Eisenberg, R.J., Cohen, G.H., Spear, P.G. and Ware, C.F. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity, 8, 21-30.
Nagata, S. (1997) Apoptosis by death factor. Cell, 88, 355-65.
Nagata, S. (1999) Fas ligand-induced apoptosis. Annu Rev Genet, 33, 29-55.
Naismith, J.H. and Sprang, S.R. (1998) Modularity in the TNF-receptor family. Trends Biochem Sci, 23, 74-9.
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T. and Inoue, J. (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells, 4, 353-62.
Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C.F., Yagita, H. and Okumura, K. (1996) TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J Biol Chem, 271, 14661-4.
Nakano, H., Sakon, S., Koseki, H., Takemori, T., Tada, K., Matsumoto, M., Munechika, E., Sakai, T., Shirasawa, T., Akiba, H., Kobata, T., Santee, S.M., Ware, C.F., Rennert, P.D., Taniguchi, M., Yagita, H. and Okumura, K. (1999) Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci U S A, 96, 9803-8.
Pan, G., O''Rourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J. and Dixit, V.M. (1997) The receptor for the cytotoxic ligand TRAIL. Science, 276, 111-3.
Park, Y.C., Burkitt, V., Villa, A.R., Tong, L. and Wu, H. (1999) Structural basis for self-association and receptor recognition of human TRAF2. Nature, 398, 533-8.
Park, Y.C., Ye, H., Hsia, C., Segal, D., Rich, R.L., Liou, H.C., Myszka, D.G. and Wu, H. (2000) A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell, 101, 777-87.
Prasad, K.V., Ao, Z., Yoon, Y., Wu, M.X., Rizk, M., Jacquot, S. and Schlossman, S.F. (1997) CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci U S A, 94, 6346-51.
Regnier, C.H., Tomasetto, C., Moog-Lutz, C., Chenard, M.-P., Wendling, C., Basset, P. and Rio, M.-C. (1995) Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-associated Protein Family, Which Is Expressed in Breast Carcinoma. J. Biol. Chem., 270, 25715-25721.
Rennert, P.D., Browning, J.L. and Hochman, P.S. (1997) Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol, 9, 1627-39.
Rothe, M., Wong, S.C., Henzel, W.J. and Goeddel, D.V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell, 78, 681-92.
Sato, T., Irie, S. and Reed, J.C. (1995) A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett, 358, 113-8.
Schneider, P., Thome, M., Burns, K., Bodmer, J.L., Hofmann, K., Kataoka, T., Holler, N. and Tschopp, J. (1997) TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity, 7, 831-6.
Schwandner, R., Yamaguchi, K. and Cao, Z. (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med, 191, 1233-40.
Shinkura, R., Kitada, K., Matsuda, F., Tashiro, K., Ikuta, K., Suzuki, M., Kogishi, K., Serikawa, T. and Honjo, T. (1999) Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat Genet, 22, 74-7.
Sprick, M.R., Weigand, M.A., Rieser, E., Rauch, C.T., Juo, P., Blenis, J., Krammer, P.H. and Walczak, H. (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity, 12, 599-609.
Takaori-Kondo, A., Hori, T., Fukunaga, K., Morita, R., Kawamata, S. and Uchiyama, T. (2000) Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling. Biochem Biophys Res Commun, 272, 856-63.
Takeuchi, M., Rothe, M. and Goeddel, D.V. (1996) Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J Biol Chem, 271, 19935-42.
Tamada, K., Shimozaki, K., Chapoval, A.I., Zhu, G., Sica, G., Flies, D., Boone, T., Hsu, H., Fu, Y.X., Nagata, S., Ni, J. and Chen, L. (2000) Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med, 6, 283-9.
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H. and Nagata, S. (1996) Fas ligand in human serum. Nat Med, 2, 317-22.
Tartaglia, L.A., Ayres, T.M., Wong, G.H. and Goeddel, D.V. (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell, 74, 845-53.
VanArsdale, T.L., VanArsdale, S.L., Force, W.R., Walter, B.N., Mosialos, G., Kieff, E., Reed, J.C. and Ware, C.F. (1997) Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB. Proc Natl Acad Sci U S A, 94, 2460-5.
Wajant, H., Grell, M. and Scheurich, P. (1999) TNF receptor associated factors in cytokine signaling. Cytokine Growth Factor Rev, 10, 15-26.
Walczak, H., Degli-Esposti, M.A., Johnson, R.S., Smolak, P.J., Waugh, J.Y., Boiani, N., Timour, M.S., Gerhart, M.J., Schooley, K.A., Smith, C.A., Goodwin, R.G. and Rauch, C.T. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. Embo J, 16, 5386-97.
Wallach, D., Varfolomeev, E.E., Malinin, N.L., Goltsev, Y.V., Kovalenko, A.V. and Boldin, M.P. (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol, 17, 331-67.
Wiley, S.R., Goodwin, R.G. and Smith, C.A. (1996) Reverse signaling via CD30 ligand. Journal of Immunology, 157, 3635-9.
Williams-Abbott, L., Walter, B.N., Cheung, T.C., Goh, C.R., Porter, A.G. and Ware, C.F. (1997) The Lymphotoxin-alpha (LTalpha ) Subunit Is Essential for the Assembly, but Not for the Receptor Specificity, of the Membrane-anchored LTalpha 1beta 2 Heterotrimeric Ligand. J. Biol. Chem., 272, 19451-19456.
Wu, M.Y., Hsu, T.L., Lin, W.W., Campbell, R.D. and Hsieh, S.L. (1997) Serine/threonine kinase activity associated with the cytoplasmic domain of the lymphotoxin-beta receptor in HepG2 cells. J Biol Chem, 272, 17154-9.
Wu, M.Y., Wang, P.Y., Han, S.H. and Hsieh, S.L. (1999) The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells. J Biol Chem, 274, 11868-73.
Xu, Y., Cheng, G. and Baltimore, D. (1996) Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity, 5, 407-15.
Ye, H., Park, Y.C., Kreishman, M., Kieff, E. and Wu, H. (1999) The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell, 4, 321-30.
Yeh, W.C., Hakem, R., Woo, M. and Mak, T.W. (1999) Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling. Immunol Rev, 169, 283-302.
Yeh, W.C., Pompa, J.L., McCurrach, M.E., Shu, H.B., Elia, A.J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., El-Deiry, W.S., Lowe, S.W., Goeddel, D.V. and Mak, T.W. (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science, 279, 1954-8.
Yeh, W.C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J.L., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D.V. and Mak, T.W. (1997) Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity, 7, 715-25.
You, L.R., Chen, C.M. and Lee, Y.H.W. (1999) Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol, 73, 1672-81.
Yu, K.-Y., Kwon, B., Ni, J., Zhai, Y., Ebner, R. and Kwon, B.S. (1999) A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis. J. Biol. Chem., 274, 13733-13736.
Zhai, Y., Guo, R., Hsu, T.L., Yu, G.L., Ni, J., Kwon, B.S., Jiang, G.W., Lu, J., Tan, J., Ugustus, M., Carter, K., Rojas, L., Zhu, F., Lincoln, C., Endress, G., Xing, L., Wang, S., Oh, K.O., Gentz, R., Ruben, S., Lippman, M.E., Hsieh, S.L. and Yang, D. (1998) LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest, 102, 1142-51.
|